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In the ﬁeld of molecular and cellular neuroscience, it is not a trivial task to see the forest for the trees,
where numerous, and seemingly independent, molecules often work in concert to control critical steps
of synaptic plasticity and signalling. Here, we will ﬁrst summarize our current knowledge on essential
activity-dependent transcription factors (TFs) such as CREB, MEF2, Npas4 and SRF, then examine how
various transcription cofactors (TcoFs) also contribute to deﬁning the transcriptional outputs during
learning and memory. This review ﬁnally attempts a provisory synthesis that sheds new light on some
of the emerging principles of neuronal circuit dynamics driven by activity-regulated gene transcription
to help better understand the intricate relationship between activity-dependent gene expression and
cognitive behavior.
 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-SA
license (http://creativecommons.org/licenses/by-nc-sa/3.0/).1. Introduction
Over the last 25 years or so, it has become evident that activity-
dependent gene expression plays essential roles in not only
globally controlling memory persistence, but most importantly
also to deﬁne and determine the genesis and decay of local mem-
ory traces. Signiﬁcant cognitive deﬁcits were associated with aber-
rant functions of activity-dependent transcription factors (TFs)
both in mice and in humans (West & Greenberg, 2011). Consistent
with this notion, many of their target genes that are strongly
induced by neuronal activity (often referred to as immediate early
genes (IEGs)) show high utility as biomarkers of activated neurons
(Okuno, 2011). Conversely, disturbed IEG expression correlates
with cognitive disorders under many pathophysiological states
(Cohen & Greenberg, 2008). Recent evidence has further revealedthat activity-regulated TFs may not just function as molecular
switches that activate IEG promoters to control expression of
downstream genes. The state of activity-regulated TFs might
dynamically allocate memory within a functional neuronal circuit
(Liu et al., 2012; Mayford, 2014; Yiu et al., 2014), and this may
be a mechanism to assign the active neuronal ensemble that
deﬁnes a memory engram within a given brain area (Silva, Zhou,
Rogerson, Shobe, & Balaji, 2009). A number of recent IEG pro-
moter-based labeling and cell manipulation studies support this
idea (Kawashima, Okuno, & Bito, 2014). However, key conceptual
advances sometimes fail to draw public attention, especially when
early critical ﬁndings are fragmented and presented in many differ-
ent and controversial pieces.
Here we will aim to ﬁrst summarize recent advances in
the research of individual activity-dependent TFs (Table 1),
then will present an outlook of the technical advances that
recently provide a new framework for understanding activity-
dependent gene expression in the context of cognitive behav-
ioral neuroscience.
Table 1
Brief summary of basic properties and recent ﬁndings on transcription factors/cofactors related to cognitive functions described in the Sections 1–5 of the text.
Activity-dependent
transcription factor
Target sequence Cofactor Localization and activation Downstream genes
(e.g., Cognitive effects)
References
CREB CRE CRTC1,
CBP
Constitutively bound to target
Ca2+-dependent
phosphorylation
c-fos, Arc, BDNF, Egr-1 Memory enhancer Josselyn et al. (2001)
Han et al. (2007)
MEF2 MRE CBP Constitutively nucleus c-fos, Arc Memory repressor Flavell et al. (2008)
Rashid et al. (2014)
Npas4 Not determined Ca2+-dependent Npas4
induction and DNA binding
BDNF Regulation of inhibitory/
excitatory circuits
Lin et al. (2008)
Spiegel et al. (2014)
SRF SRE TCL,
MKL1
Constitutively bound to the
target
c-fos, Arc, Egr-1 LTP induction and
maintenance/LTD
maintenance
Ramanan et al. (2005)
Posern and Treisman
(2006)
DREAM /
KChIP3
DRE (Shared with CREB/
CREM binding sites)
Ca2+ binding dependent
release form the promoter
c-fos, Npas4, Mef2c DG-enriched LTP
enhancer
Carrion et al. (1999)
Mellstrom et al. (2014)
MeCP2 Methyl CpG Ca2+-triggered
phosphorylation
dependent release from
the promoter
CREB, BDNF, Sst, Mef2c causative gene for
Rett syndrome
(a type of autism)
Guy et al. (2011)
Chahrour et al. (2008)
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transcription factor that facilitates memory formation: CREB
Ca2+/cyclic AMP response element-binding protein (CREB) is
widely expressed in the brain and other organs, throughout devel-
opment, and is critical in many forms of cognitive behavior, includ-
ing memory formation and allocation (Bourtchuladze et al., 1994;
Gruart, Benito, Delgado-Garcia, & Barco, 2012; Han et al., 2007;
Kida et al., 2002; Silva, Kogan, Frankland, & Kida, 1998; Silva
et al., 2009; Suzuki et al., 2011; Yin et al., 1994; Zhou et al.,
2009). CREB is further implicated in many brain functions such
as neuronal survival, proliferation, ischemia, circadian clock, plas-
ticity, and feeding behavior (Gau et al., 2002; Mantamadiotis
et al., 2002; Martin & Kandel, 1996; Nonaka, 2009). Despite its
overwhelming importance, the pursuit of what deﬁnes its regional
and downstream speciﬁcity has remained rather elusive.
Essentially, CREB localizes in the nucleus, binds to a cAMP-
responsive element (CRE) sequence, -TGACGTCA-, and is activated
downstream of various kinase cascades stimulated by cAMP, Ras,
and/or Ca2+ signaling, all of which converge on the phosphorylation
of Ser133 residue (Arthur et al., 2004; Bito et al., 1996; Finkbeiner
et al., 1997; Ginty et al., 1994; Gonzalez & Montminy, 1989;
Hardingham et al., 1997; Impey et al., 1996; Naqvi et al., 2014;
Sheng et al., 1991). CREB associates with well-known co-factors,
CREB binding protein (CBP) and its homologue p300 (Goodman &
Mandel, 1998). These bind to p-Ser133 of CREB in response to exter-
nal stimuli and then recruit the RNA polymerase II-containing tran-
scription initiation complex, while they also acetylate histone to
loosen the nearby chromatin structure. CBP chromatin immunopre-
cipitation (ChIP)-seq data revealed that upon stimulation CBP-bind-
ing sites on the whole genome increased from 1000 to 28,000
(Kim et al., 2010). CBP/p300 were shown to have possible crosstalk
with TFs other than CREB (Ramos et al., 2010). These lines of evi-
dence suggest that CBP may not be a CREB-speciﬁc cofactor, but
rather a common scaffold for RNA polymerase II at enhancers and
promoters. This study further indicated that CBP and p300, seem-
ingly redundant transcriptional cofactors (TcoFs), displayed some
extent of speciﬁcity (Ramos et al., 2010).
Recent evidence indicated that CREB phosphorylation at Ser133
may not be the sole CREB activation mechanism in all CREB-regu-
lated genes. Comparative CREB ChIP-chip analysis in different cell
types revealed that out of 4000 gene promoters occupied by
CREB, transcription of only 100 genes was actually up-regulated
in response to forskolin, a cAMP production stimulant. Further-
more, distinct cell types showed differential induction of alternatesets of 100 genes although there was no speciﬁcity at the level of
either CREB expression or p-CREB status (Zhang et al., 2005). Thus,
novel mechanisms that determine cellular speciﬁcity of CREB acti-
vation await to be identiﬁed.
Coincidently, CREB-regulated transcriptional co-activator
(CRTC) or transducer of regulated CREB activity (TORC) was identi-
ﬁed as a co-factor that binds the bZIP domain of CREB, and activate
CREB in a manner that acts in parallel to CREB phosphorylation
(Altarejos & Montminy, 2011; Conkright et al., 2003). Of three
known isoforms, CRTC1-3, CRTC1 is the dominant TcoF isoform
expressed in the nervous system (Watts, Sanchez-Watts, Liu, &
Aguilera, 2011). CRTC1 translocates from cytosol to nucleus in
response to synaptic activity (Ch’ng et al., 2012) and its overex-
pression in the hippocampus results in enhanced contextual mem-
ory (Nonaka et al., 2014; Sekeres et al., 2012). Furthermore, CRTC1
regulates dendritic morphology (Li, Zhang, Takemori, Zhou, &
Xiong, 2009). In vivo studies suggested that CRTC1 promotes tran-
scription of CRE-dependent genes such as c-fos, BDNF, Arc (also
termed as Arc/Arg3.1) and Egr-1(also termed as zif-268), and
revealed interesting brain region-speciﬁcity in regulation of task-
dependent CRTC1 nuclear shuttling (Nonaka et al., 2014). There-
fore, CRTC1 might play a role in determining CREB speciﬁcity at
both the circuit and the chromosomal levels in the brain.
3. An activity-dependent transcription factor that represses
memory: MEF2
Myocyte enhancer factor-2 (MEF2) is a TF that has originally
been characterized for its role during muscle development. It is
now evident, however, that MEF2 regulates neuronal development
and survival. MEF2 has four isoforms, MEF2A-D, which are
expressed in a brain-region speciﬁc manner (Rashid, Cole, &
Josselyn, 2014). It constitutively localizes in the nucleus and binds
to MRE. The consensus motif of MRE appears more tolerant in brain
(underlined sequence of TGTTACT(A/t)(a/t)AAATAGA(A/t)) than as
found in the muscle, which might account for how MEF2 induces
distinct sets of genes in those tissues (Andres, Cervera, &
Mahdavi, 1995). Transcriptome analyses using MEF2-deﬁcient
cells identiﬁed many downstream genes including c-fos and Arc
(Flavell et al., 2008).
An emerging view for the role of MEF2 in cognition in the
mature brain is that MEF2 may act as a repressor for memory
(Rashid et al., 2014). MEF2 may gate memory formation as it
undergoes task-dependent phosphorylation and degradation.
MEF2 also negatively regulates spine density (Cole et al., 2012;
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promoter driven expression of an active form of MEF2 (MEF2-
VP16) in transgenic mice showed little effect in a fear conditioning
test, an HSV-mediated, temporally and spatially restricted, overex-
pression of MEF2-VP16 revealed suppression of fear and spatial
memory, while active MEF2 also inhibited the task-dependent
increase in spine density (Cole et al., 2012). Conversely, blocking
MEF2 function by HSV-mediated expression of a dominant nega-
tive form of MEF2 facilitated memory formation (Cole et al.,
2012). These lines of experiments suggest a technical advantage
for a virus-mediated and local expression strategy in delineating
causality.
This negative regulation for spatial memory and fear memory
might be mediated at least in part by Arc, as Arc overexpression
was previously shown to facilitate AMPAR internalization
(Chowdhury et al., 2006; Okuno et al., 2012; Shepherd et al.,
2006). However, Arc is also upregulated downstream of CREB and
SRF, both of which are believed to correlate with enhanced mem-
ory. Treatment with memory-enhancing drugs also commonly
triggers induction of IEGs that include known MEF2 target genes.
Therefore, further investigation is clearly needed to tease apart
the critical contribution of MEF2, vis-à-vis of the TF network that
controls transcriptional signal processing underlying memory for-
mation (Rashid et al., 2014).4. A new kid on the block: Npas4
Npas4 is a bHLH-type TF that is stringently induced by Ca2+-
inﬂux driven voltage-gated channels, but not by neurotrophic fac-
tors or cAMP increases in neurons (Lin et al., 2008). Hence, Npas4
itself is an IEG, which is induced by synaptic activity both in excit-
atory and inhibitory neurons (Spiegel et al., 2014) as well as during
ischemia and seizure (Maya-Vetencourt, 2013). Consistent with
the fact that the Npas4 is activity-induced, genome-wide ChIP-
seq conﬁrmed the absence of Npas4 binding in the activity-
silenced state, in sharp contrast to CREB and SRF, a large portion
of which are constitutively bound to their targets (Kim et al.,
2010). The function of Npas4 is associated with formation and
maintenance of GABAergic inhibitory synapses as part of a homeo-
static excitability regulation mediated in part through its direct
target BDNF (Lin et al., 2008; Spiegel et al., 2014). Furthermore,
Npas4 in hippocampal CA1 was revealed to contribute to a speciﬁc
facilitation of inhibitory synapse formation around the soma, while
inhibitory synapses were reduced in the apical dendrites
(Bloodgood, Sharma, Browne, Trepman, & Greenberg, 2013). Such
Npas4-mediated rewiring will have a signiﬁcant impact on infor-
mation processing in the CA1 pyramidal neurons, as an increase
in somatic inhibitory inputs will reduce cell ﬁring, while a reduc-
tion in dendritic inhibitory inputs will affect gating of local inputs.
Another region-speciﬁc behavioral contribution was reported
for Npas4; a virus-mediated local deletion in CA3, but not in CA1,
impaired fear memory (Ramamoorthi et al., 2011). Therefore,
Npas4 may mediate a region-speciﬁc rewiring and plasticity pro-
cesses within the hippocampus.
Such region speciﬁcity and cell type speciﬁcity (inhibitory and
excitatory neurons) of TFs’/TcoFs’ functions has often been over-
looked in classical global genetic manipulations but is now being
probed using local virus injection and neuronal subtype-speciﬁc
Cre transgenic approaches (Spiegel et al., 2014).5. A critical role for SRF in circuit rewiring and plasticity
Serum responsive factor (SRF) is a MADS domain-containing TF
that binds to the sequence, CC(A/T)6GG (called CArG box) within an
SRE and plays important roles in mesoderm and muscle develop-ment, anti-apoptotic processes, neuronal migration and synaptic
plasticity. Its downstream genes in neurons include a large body
of IEGs, such as c-fos, Arc and Egr-1, just to name a few. SRF activa-
tion is mainly dependent on its TcoFs, Elk1, a member of the ter-
nary complex factor (TCF), and Megakaryoblasic Acute Leukemia-
1 (MAL/MKL1), a member of the myocardin-related transcription
factor (MRTF) (Besnard, Galan-Rodriguez, Vanhoutte, & Caboche,
2011; Kalita, Kuzniewska, & Kaczmarek, 2012). TCF and MAL share
the same binding region on the DNA binding site of SRF. Thus, the
binding of TCF and MAL occurs in a mutually exclusive manner
(Posern & Treisman, 2006). Certain SRE elements appeared to be
biased towards preferential binding of either SRF/TCF or SRF/MAL
complexes, implying the speciﬁc contribution of either of the
cofactors for the promoters. This alternative cofactor system might
contribute to the tissue/region- and/or developmental stage-spe-
ciﬁc induction of some SRF-dependent genes. SRF has distinct roles
in glial cells and neurons. SRF is implicated in glial speciﬁcation (Lu
& Ramanan, 2012) and SRF in astrocytes may modulate ocular
dominance plasticity (Paul et al., 2010). In neurons, SRF is not
essential for survival but is critical for induction and maintenance
of LTP (Ramanan et al., 2005) and maintenance of LTD (Etkin et al.,
2006; Smith-Hicks et al., 2010). TCF activation via MAPK-ERK1/2
pathway is well established, but it has been shown that synaptic
activity is also activating MAL through ERK1/2 (Kalita, Kharebava,
Zheng, & Hetman, 2006). MAL is regulated downstream of the
RhoA signalling pathway. G-actin depletion releases MAL to trans-
locate to the nucleus (Tabuchi et al., 2005). Srf conditional knock-
out (Srf/; Camk2a-iCre) revealed severe defects in neuronal
axon branching, dendrites, and spine morphology (Stritt & Knoll,
2010). It is as yet not clear whether SRF may also regulate activ-
ity-dependent circuit rewiring in the adult brain in association
with plasticity regulation in a manner similar to the case of Npas4.6. Important co-factors that modulate IEG transcription:
DREAM and MeCP2
DREAM (downstream regulatory element antagonist modulator
or antagonist modulator of DRE sites), also termed as KChIP3 or
calsenilin, is a Ca2+-regulated transcription modulator that
represses transcription when bound to target DRE sites (-GTCA-
or inverted sequence, -TGAC-). It is unique in that DREAM is
directly regulated by Ca2+ through its four EF hands. Upon Ca2+
binding, DREAM unbinds from DRE sites, thus removing the inacti-
vation of transcription (Carrion, Link, Ledo, Mellstrom, & Naranjo,
1999). This protein is speciﬁcally enriched in the hippocampal den-
tate gyrus (DG). Upon contextual fear conditioning test, it translo-
cates from the plasmamembrane Kv channels, to the nucleus in 6 h
to suppress target gene expression. The dissociation of DREAM/
KChIP3 from Kv channels will contribute to enhanced A-currents,
which in turn alter general excitability and LTP induction property.
The negatively regulated targets include Prodynorphin, c-fos, ICER,
and CREM (Ledo et al., 2000). Presumably because of compensation
by other KChIP isoforms, a general DREAM knockout barely dis-
played any neuronal phenotypes. DREAM has been reported to
associate with the KID domain of CREB or some CREM isoforms,
and thus interfere with CREB-CBP binding. Upon Ca2+ binding,
DREAM is released from CREB/CREM, while in parallel, CREB
phosphorylation cause a conformational change that strongly
favors CBP binding (Ledo, Kremer, Mellstrom, & Naranjo, 2002).
Although the exact details of this pathway are yet to be deter-
mined, DREAM might serve as a DG-speciﬁc regulator for Ca2+ sig-
nalling to CREB-CBP complex formation. Consistent with this idea,
DREAM knockouts show enhanced contextual fear memory
(Alexander et al., 2009), and transgenic mice expressing a domi-
nant active DREAM (daDREAM) showed strong deﬁcits in water-
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test, all of which involves the hippocampus (Mellstrom et al.,
2014). In keeping with evidence that Npas4 and BDNF are regulated
by DREAM, daDREAM transgenic mice showed downregulation of
GABAergic synapses and enhanced LTP in DG (Mellstrom et al.,
2014).
MeCP2 is an epigenetic repressor of transcription that binds to
the methylated CpG, within a large number of promoters including
that of the BDNF gene. Mutations in the MeCP2 gene are causative
for a majority of familial cases of the Rett syndrome, although the
exact cell type/brain region in which MeCP2 dysregulation is most
critical still remains debated (Castro, Mellios, & Sur, 2013; Guy,
Cheval, Selfridge, & Bird, 2011). Upon Ca2+-triggered phosphoryla-
tion, MeCP2 unbinds from its target locus and from co-repressor,
NCoR, thus enabling restart of transcription (Cohen et al., 2011;
Ebert et al., 2013). Surprisingly, it has been reported that MeCP2
may have a distinctive region-speciﬁc role in the hypothalamus
where it acts as an activator for most of the target genes, partially
collaborating with CREB on some (e.g. somatostatin) but not all
CRE-dependent genes (Chahrour et al., 2008). In this context, CREB
itself is a positive target of MeCP2.7. Taking advantage of technical breakthroughs in molecular
virology to address the functional speciﬁcity of activity-
dependent transcription factors in vivo
An exciting new development in the ﬁeld of activity-dependent
TFs is the growing availability of localized transcriptome data
(Benito & Barco, 2014) and of new viral vector tools (Dreyer,
2011; Varenika et al., 2009). The former enables the identiﬁcation
of critical brain regions of transcriptional dysregulation, while the
latter allows critical manipulation of transcriptional mechanisms
with high spatial and temporal precision.
Virus-mediated brain region-speciﬁc interrogative approaches
have proven to be invaluable in complementing conventional glo-
bal transgenic approaches (simpliﬁed overview summarized in
Fig. 1A). The combination of Cre-transgenic lines with virus-med-
iated expression cassettes, for example, currently enables the
most sophisticated degree of cell-type and regional speciﬁcity
required for circuit mapping. However, with improved protocols
for high-titer viral vectors (HSV, AAV, or lentivirus), it has become
possible to study behavioral phenotypes for speciﬁc gene knock-
down/knockout or overexpression of a gain-of-function/dominant
loss-of-function mutants of any transcriptional regulators
(Adachi, Barrot, Autry, Theobald, & Monteggia, 2008; Berton
et al., 2006; Han et al., 2007; Josselyn et al., 2001) (Fig. 1,
Table 2).
In certain cases, proper selection of virus (and serotypes) and
tissue-/celltype-speciﬁc promoters may be necessary for designing
experiments. HSV, lentivirus, and AAV-mediated gene manipula-
tion achieves different expression time courses and spatial spreads
within the brain. HSV will express the proteins of interests within a
few days after injection, then cease the expression in a week, while
lentivirus and AAV-mediated expression will gradually increase
and last onwards (Table 2 for references). Due to the particle size
of the virus, AAV will generally spread in a larger area than
lentivirus, but this feature also depends on the serotypes. These
differences in temporal kinetics and spatial spreads of virus-med-
iated expression have implications on how behavioral phenotypes
are to be tested (Table 2).
We should bear in mind that virus infection may not be
achieved in all neurons in the area of virus spread and region-spe-
ciﬁc conﬁnement and infectivity may usually be deﬁned by a com-
plex function of physical spread of the viral solution, the viral titer
and the promoter strength. For loss-of function studies, injection ofthe Cre virus (that expresses Cre recombinase) into a ﬂoxed mice
(in which a speciﬁc portion of a gene is ﬂanked by loxP sequences
and ready to be excised by Cre-dependent recombination) will cre-
ate region-speciﬁc knockouts (Berton et al., 2006). In contrast, AAV
or lentivirus or HSV-mediated shRNA expression will work as
region-speciﬁc knockdowns. Careful interpretation of physiological
and behavioral data is necessary to account for the potential resid-
ual effect due to insufﬁcient infection efﬁciency and gene excision/
knockdown efﬁciency. The mozaicism of viral expression might
sometimes be desirable. For example, Bloodgood et al. (2013) used
a combination of Npas4 ﬂox-mouse and Cre virus injection, which
created a mosaic area within the virus-injected brain region and
thus enabled them to simultaneously record electrically from both
recombination-positive (thus KO) cells and juxtaposed negative
(wild-type) cells.8. Advanced tools for examining the causality of neuronal
activity traces in vivo
To determine the causal role of activity-dependent gene expres-
sion, it is critical to tightly control the experimental time window
for knockdown/knockout or gain-of-function gene expression,
especially when those genetic modiﬁcations are to be restricted
within certain phases of behavior tasks. Orthogonal recombinase
systems, such as the Cre-loxP and the FLP-FRT systems, the tamox-
ifen-CreERT2 and the doxycycline-TetON/OFF systems could prove
to be very powerful, if the two gene activation events to be com-
bined require a controlled temporal and spatial sequence.
Improved designs of customized dual cassette vectors will particu-
larly be helpful in such attempts (e.g. Kawashima et al., 2013).
Viral technologies (Jennings & Stuber, 2014) have been exten-
sively exploited in elucidating the causal role of CREB in learning
and memory. Based on the ﬁnding that forced expression of CREB
in a subset of neurons at encoding will facilitate recruitment of a
memory engram in CREB-positive neurons, several groups have
now successfully modiﬁed memory performance by altering neu-
ronal activity of these CREB-engram neurons by co-expression of
effector proteins (Table 2) (Czajkowski et al., 2014; Han et al.,
2007; Kim, Kwon, Kim, Josselyn, & Han 2014; Zhou et al., 2009).
Furthermore, CREB-dependent recruitment of memory engrams
was recapitulated by increasing excitability in a subset of neurons
with virally expressed effectors such as dnKCNQ and the pharma-
cogenetic DREADD Gq system (Yiu et al., 2014). Independently,
activity-dependent promoters were used to deﬁne the memory
engram and to manipulate the activity of those engram neurons
using optogenetic (Liu et al., 2012; Ramirez, Tonegawa, & Liu,
2013) or pharmacogenetic (Garner et al., 2012) effector proteins.
One attractive next-generation technology in the ﬁeld of TF/
TcoF research is the light-inducible transcriptional effectors, such
as LITE (Konermann et al., 2013). While the potency of light-
induced transcriptional activation still needs to be further opti-
mized, this technique holds strong promise for future application
in intact brain, using AAV for example, to trigger expression of spe-
ciﬁc set of IEGs with even higher temporal and spatial precision
in vivo.9. Cooperativity and combinatorial selectivity via crosstalk of
activity-dependent transcription factors: towards a better
understanding of activity-dependent gene expression in active
neuronal ensembles
While numerous work has demonstrated that activity-depen-
dent TFs play critical roles in cognition, it is yet not clear how
co-activation of several activity-dependent TFs helps achieve
xx
x
x
x
(1) Loss-of-function
(2) Region-specific rescue in global KO animals
=
=
=
=
=
=
=
x
x
(3) Gain-of-function / Reporter / Effector expression
(1-1)
(1-2)
(1-3)
(3-1)
(3-2)
(3-3)
Flox (KO) animal Cre animal Region-specific KO
Flox (KO) animal Cre virus Region-specific KO
WT animal KD virus Region-specific KD
KO animal expression virus Region-specific rescue
Cre animal Flox (expression) mouse Region-specific expression
Cre animal Flox (expression) virus Region-specific expression
WT animal Expression virus Region-specific expression
A B
Fig. 1. (A) Simpliﬁed view of novel molecular virological strategies for brain-region speciﬁc genetic medication in vivo. (1-1) In loss-of-function studies, the currently
standard method is to cross a conditional (ﬂoxed) KO animal with a Cre animal (which expresses Cre recombinase in a region- or population-speciﬁc manner). (1-2)
Alternatively, we can use a viral expression vector encoding a Cre recombinase. This virus-mediated method is time-saving and sometimes even beneﬁcial over Cre animal, in
which the expression pattern of Cre may not be perfectly ideal. Use of low-titer Cre-virus results in the mosaic KO, which is sometimes suited for slice electrophysiology as
well as morphological and immunohistochemical assays to test cell autonomy of the gene deletion effect. (1-3) Wild-type animal infected with knockdown-virus into the
brain region of interest. (2) Targeted virus injection is also useful for the rescue experiment of global KO animals to verify that restoring the expression of the molecule in the
particular region is sufﬁcient to rescue the phenotypes. (3) In gain-of-function studies such as wild-type overexpression or active-form expression, Cre driver animal is
crossed with conditional Flox-mediated gene expression line (3-1). (3-2) Injection of virus with Flox-mediated expression are also commonly used for localized gene
expression. (3-3) Simply injecting gene-expression virus into wild-type animal is also a powerful way of region-speciﬁc genetic modiﬁcation. The promoter of the expression
cassette in the virus confers brain region- or celltype- speciﬁcity, when the size of the promoter is small enough to be inserted into a viral vector cassette. In experiments
using activity-reporters or light-sensitive probes, such as GCaMP, or effector molecules, such as ChR2/NpHR/Arch, the same approaches as those used for gain-of-function are
applicable. However, for better cell-type speciﬁcity, the combination of Cre animal and the Flox-mediated effector virus is more commonly used. (B) Serial section of AAV-GFP
infection targeted to bilateral hippocampus in wild-type mouse. Scale, 1 mm. The virus-only approaches using wild-type animals in Fig. 1A, (1-3) and (3-3) are effective in
selectively targeting distinct brain structures such as the hippocampus, the amygdala, or the olfactory bulb. In experienced hands and with optimized viral titration/
serotypes, it is also quite feasible to infect only a subregion such as CA1, CA3, or DG areas only.
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occupancy state of various TF-binding sites and the speciﬁc regula-
tion of each bound TF are likely to be at the heart of this complex
regulatory mechanism, as demonstrated in the case of SARE
element in the distal enhancer of the Arc gene (Kawashima et al.,
2009) or in the CaRE element of the BDNF promoter (West et al.,
2001). The modularity for many regulatory elements and the dem-
onstration of multiple TF binding cassettes within critical enhan-
cer/promoter regions now appear to be a dominant rule in most
known enhancers of IEGs and in many genes across genomes
(Kim et al., 2010; Rodriguez-Tornos, San Aniceto, Cubelos, &
Nieto, 2013).Expression of many activity-dependent TFs such as CREB, MEF2,
and SRF is widespread across many brain regions. However, these
must also possess differential roles in different brain regions and
control distinct sets of downstream genes that are to be induced
in each of these regions. How can such speciﬁcity be generated?
As reviewed in many instances above, TcoFs, such as CRTC for CREB
and TCF/MAL for SRF, are activity-dependently regulated in them-
selves and appear to add a layer of complexity to relatively simple
regulations of TFs. Therefore, TcoFs may be crucial players that help
deﬁne the speciﬁc contexts of activity-dependent gene induction:
where, when, to what extent, and what sets of genes are induced
during cognition (Fig. 2). Understanding how the speciﬁcity of
Table 2
Recent works on transcription factors/cofactors in neurons using a viral approach Sindbis virus has initially been used for forced expression of wild-type, active form and
dominant negative forms of the TFs in behavior assessment, but was recently replaced by HSV, lentivirus and AAV for some reasons such as cell toxicity, safety and handling. In
addition to in vivo application, lentivirus has also been effectively used in in vitro biochemical assays. Virus-mediated knockdown methods have been pioneered by (Hommel,
Sears, Georgescu, Simmons, & DiLeone, 2003). For comprehensive lists of the viral constructs speciﬁcally for CREB research, refer to (Barco & Marie, 2011). Please note that this is
not an exclusive survey and that the ﬁndings listed here do not cover all the contents of the reference papers.
Virus Construct Experiments Findings References
Studies to investigate the transcription factor/cofactor functions
Sindbis
virus
Sindbis-
expression
CREB gain of function (behavior) (CA1, DG) CREB "? CFC " Restivo et al. (2009) and Vetere,
Marchetti, et al. (2011)
Lentivirus Lenti-sh Npas4 knockdown (in culture) Microarray identiﬁed Npas4
downstream genes
Lin et al. (2008)
Lenti-sh Mef2 knockdown (in culture) Microarray identiﬁed MEF2
downstream genes
Flavell et al. (2008)
Lenti-sh NeuroD2 knockdown (morphology) (CA3) NeuroD2 ; ? spine density ; Wilke et al. (2012)
Lenti-expression CREB mutant expression (behavior) (dHPC) CREB ; ? CFC " Kathirvelu, East, Hill, Smith, and
Colombo, (2013)
Lenti-expression CREB expression (behavior) (dStr) CREB "? CFC " Kathirvelu and Colombo (2013)
Lenti-expression CRTC1 active form expression (morphology) (CA1) CRTC1 "? spine volume " Nonaka et al. (2014)
HSV HSV-expression CREB expression study (behavior) (BLA) CREB "? Light FC " Josselyn et al. (2001)
HSV-expression CREB expression study (behavior) (LA) CREB "? Auditory FC " Han et al. (2007)
HSV-Cre Npas4 knockout (behavior, in culture) (CA3) Npas4 ; ? CFC ; Ramamoorthi et al. (2011)
(culture) Npas4 ; ? IEG;
HSV-expression Mef2 gain of function study (behavior) (DG) MEF2 "?WM;, (LA)
MEF2 "? FC;
Cole et al. (2012)
(DG) MEF2 ; ?WM ", (LA) MEF2 ;
? FC "
HSV-expression CRTC1 gain of function study (behavior) (DG) CRTC1 "? CFC " Sekeres et al. (2012)
AAV AAV-sh Mef2 knockdown and gain of function (behavior,
morphology)
(NAc) MEF2 ; ? spine density " Pulipparacharuvil et al. (2008)
(NAc) MEF2 "? sensitization to
cocaine "
AAV-sh CREB knockdown (behavior) (NAc) CREB ; ? cocaine CPP " Green et al. (2010)
AAV-Cre CBP knockout (behavior) (CA1) CBP ; ? CFC ;, spatial obj.
recognition ;
Barrett et al. (2011)
AAV-sh Npas4 knockdown (behavior) (LA) Npas4 ; ? Auditory FC ; Ploski, Monsey, Nguyen, DiLeone, and
Schafe (2011)
scAAV MeCP2 knockout phenotype rescue (behavior) (systemic) MeCP2 "?motor task " Garg et al. (2013) and Gadalla (2013)
AAV-Cre Npas4 knockout (electrophysiology) (CA1) Npas4 ; ?mIPSC freq (after
EE);
Bloodgood et al. (2013)
AAV-sh, AAV-
expression
CRTC1 knockdown and gain of function (behavior) (BLA) CRTC1 ; ? FC ; Nonaka et al. (2014)
(dHPC) CRTC1 "? CFC "
Studies expressing effectors in transcription factor/cofactor–modulated neurons
HSV HSV-dual
expression
AlstR/ligand system (LA) Auditory FC ; Zhou et al. (2009)
HSV-dual
expression
iDTR system (LA) Auditory FC ; Han et al. (2009)
HSV-dual
expression
TRPV1 system (LA) Auditory FC " Kim et al. (2014)
HSV-expression dnKCNQ expression and DREADD (Gq) system
(independent of HSV-CREB)
(LA) Auditory FC " Yiu et al. (2014)
Abbreviations: AlstR, allatostatin G protein-coupled receptor; BLA, basolateral amygdala; CFC, contextual fear conditioning test; CPP, conditioned place preference; dHPC,
dorsal hippocampus; DG, dentate gyrus; dnKCNQ, dominant-negative KCNQ (a type of K+ channel); DREADD, Designer Receptors Exclusively Activated by Designer Drugs;
dStr, dorsal striatum; EE, enriched environment; FC, fear conditioning test; iDTR, Cre-inducible diphtheria toxin receptor; LA, Lateral amygdala; mIPSC, miniature inhibitory
postsynaptic current; NAc, nucleus accumbens; obj. recognition, object recognition; sh, short hairpin; scAAV, self-complementary AAV; TRPV1, transient receptor potential
vanilloid receptor 1; WM, watermaze task.
26 M. Nonaka et al. / Neurobiology of Learning and Memory 115 (2014) 21–29activity-dependent gene expression is generated in the brain is crit-
ical in dissecting ﬁne-tuned information processing during many
different cognitive behaviors. The interaction and combinatorial
regulation via multiple regulatory elements within promoters/
enhancers, as mentioned above, will also work as part of a multi-
layered regulatory mechanism by which the genome dictates when
and where the activity-induced genes are to be expressed.
One large caveat associated with the systematic interrogation of
activity-dependent TF functions is the fact that task-related activ-
ity occurs in sparsely distributed neurons in large brain areas dur-
ing cognitive processes, perhaps with the exception of the cases of
massive population ﬁring in pathological cases such as epileptic
seizures. Therefore, one needs to identify task-dependent active
neuronal ensembles to achieve better understanding of the link
between TF/TcoF, IEGs and the behavior. To meet such growingdemands, IEG promoters have of late been optimized to allow viral
application with a view to marking those sparse neuronal popula-
tions (Kawashima et al., 2013; Kawashima et al., 2014). Such
advance may further facilitate systematic investigation of active
ensembles, through transcriptome analysis, and calcium imaging
using activity-sensors such as a genetically encoded calcium indi-
cator, GCaMP6 (Chen et al., 2013).
One outstanding question that remains to be addressed in
future studies is to tease apart the distinctive roles of TFs of seem-
ingly opposite roles in cognitive function, which nonetheless
appears to target similar sets of IEGs. As detailed above, the coop-
erativity of many of these factors (e.g. CREB-MeCP2 and CREB-
DREAM) may not only be controlled by activity but may also
depend on the precise brain location. Comprehensive studies using
high throughput ChIP-seq/ChIP-chip of many of the activity-
Transcription factors
Transcription cofactors
Regulatory elements
Target specificity for downstream genes
Expression pattern of the cofactor
Upstream regulation of the cofactor
Tunability of the cofactor 
What
Where
When
How much
Why
Examples
CRE
CREB
CBP, CRTC1
Arc SARE, BDNF CaREs
Linking local brain region’s activity with behavior
4W1H
CRE MRE SRE
Multiple-TF binding cassettes
present in the promoters and enhancers
SARE
Defining the cellular contexts of activity-dependent gene expression 
via transcription cofactor regulation
(Kawashima et al., 2009, West et al., 2001)
(Nonaka et al., 2009, 2014)
CRTC1
Fig. 2. Transcription factors/co-factors enables the regulation of 4W1H of targeted gene expression. TFs bind target recognition DNA sequences within regulatory sequences
contained in the promoter and enhancers. Some transcription factors (TFs) are speciﬁcally expressed in some speciﬁc cell types and at selective developmental stages.
However, many TFs are ubiquitously expressed in the brain, and are known to be critical for many physiological brain functions. Therefore, there must be another level of
regulations to deﬁne the contexts for gene expression; where and when, how much of what set of genes are expressed. Here we propose a model in which the transcription
cofactors (TcoFs) help achieve a substantial degree of brain-region speciﬁcity, downstream gene set speciﬁcity, and gain control for gene expression. Multiple-transcription
factor (TF) binding modules, as discovered in some IEG promoters/enhancers, may additionally underlie controlled cooperativity and combinatorial effects, through
interactions of transcription factors and cofactors. TIC, transcription initiation complex.
M. Nonaka et al. / Neurobiology of Learning and Memory 115 (2014) 21–29 27dependent TFs/TcoFs, and RNA-Seq analyses of neurons constitut-
ing active ensembles in speciﬁc regions of the brain, during several
stages of behavior tasks, will enlighten the molecular basis of this
question. It will be also critical to reveal the region-speciﬁc avail-
ability of upstream signalling cascades and cofactors that partici-
pate in such regulation. Together, we anticipate that these
combinatorial approaches will contribute to enhance our under-
standing of molecular pathology underlying cognitive and learning
disabilities that are based on dysregulation of TFs/TcoFs, such as
Rett syndrome and Rubinstein-Taybi syndrome (Cohen &
Greenberg, 2008; Ebert & Greenberg, 2013).
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